Patent №
US 9,439,726
Granted
2016-09-13
Filed 2016
Owner
ARDIAN, INC.
+2 more
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15069830
Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
AI classification
Ownership
ARDIAN, INC.
assignment · 389740705
MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
assignment · 389760249
MEDTRONIC ARDIAN LLC
namechg · 391110924
Assignors
DEMARAIS, DENISE, GIFFORD, HANSON, III, DEEM, MARK, SUTTON, DOUGLAS, LEVIN, HOWARD R., GELFAND, MARK
On an employer assignment, the assignors are typically the inventors.